Other companies use customer reference and patient data to improve operational agility as they launch and scale their first ...
Artificial intelligence specialist Owkin has added another piece to its medical research portfolio with the launch of ...
US District Judge William Alsup's restraining order has been granted on the grounds that the Office of Personnel Management ...
I envision Chiesi as a proactive leader driving innovation and collaboration within the rare disease community. Our goal is ...
The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...
Use videos, photos, and other visual tools, where relevant, to help participants comprehend the information. Meet them where ...
The 6th TCR-based Therapies Summit returns as the only forum created solely for TCR experts pioneering best-in-class cell- ...
The meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) was scheduled for 13th March and was ...
Kyorin Pharma has signed a deal with digital health firm Hyfe to develop a digital therapeutic (DTx) for people with chronic ...
A year after the FDA rejected its marketing application for CD20xCD3 bispecific antibody odronextamab to treat two common ...
For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...
Keytruda has been approved since 2016 as a second-line option after chemotherapy for patients with more advanced HNSCC that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results